Accriva Diagnostics Recalls Hemochron Jr. APTT Test Cuvettes Due to Reagent Defect
Accriva Diagnostics is recalling Hemochron Jr. APTT test cuvettes due to a missing or mispositioned reagent that could cause inaccurate test results.
Accriva Diagnostics, Inc. has recalled certain Hemochron Jr. Whole Blood Microcoagulation System Activated Partial Thromboplastin Time (APTT) Test Cuvettes.
The recalled microcoagulation test cuvettes may have a mispositioned or absent clot activating reagent. This defect can lead to out-of-range high error codes or erroneously high test results, which may cause healthcare providers to overestimate a patient’s level of anticoagulation. An overestimation could result in inadequate anticoagulant therapy, increasing the risk of thrombosis.
The affected products were distributed nationwide in states including Massachusetts, Missouri, Alaska, West Virginia, New Jersey, Texas, Virginia, Illinois, and New York, as well as internationally in China and Colombia. The recall is categorized as Class II by the U.S. Food and Drug Administration.
What to do
- Immediately stop using the affected Hemochron Jr. APTT test cuvettes.
- Examine existing inventory to identify and quarantine any recalled units.
- Contact Accriva Diagnostics or the FDA for assistance regarding product return and replacement options.
At a glance
| Agency | U.S. Food and Drug Administration (FDA) |
|---|---|
| Recall number | Z-0317-2027 |
| Date | 2026-11-11 |
| Company | Accriva Diagnostics, Inc., San Diego, CA |
| Severity | Class II |
| Quantity | 28710 |
| Where sold | Worldwide – US Nationwide distribution in the states of MA, MO, AK, WV, NJ, TX, VA, IL, NY and the countries of China, Colombia. |
| Lot codes / identifiers | UDI-DI: 10711234103012, Lot(Expiration): B6JCA005(02/28/2027), C6JCA008(03/31/2027), D6JCA011(04/30/2027), K5JCA041(10/31/2026), C6JCA007(03/31/2027) |
Source: official FDA notice. This summary was written by 365 News from the official notice. Details can change; check the notice before acting.